SULFALEAN POWDER Poudre

Pays: Canada

Langue: français

Source: Health Canada

Achète-le

Notice patient Notice patient (PIL)
16-01-2018

Ingrédients actifs:

Sulfathiazole sodique; Sulfaméthazine sodique

Disponible depuis:

BIMEDA-MTC ANIMAL HEALTH INC

Code ATC:

Sans

Dosage:

189G; 378G

forme pharmaceutique:

Poudre

Composition:

Sulfathiazole sodique 189G; Sulfaméthazine sodique 378G

Mode d'administration:

Orale

Unités en paquet:

590G/9.1/22.7KG

Type d'ordonnance:

Prescription

Groupe thérapeutique:

Bétails; Porcs; Chevaux; Mouton

Domaine thérapeutique:

objet

Descriptif du produit:

Numéro de groupe d'ingrédients actifs (GIA) :0206063001

Statut de autorisation:

APPROUVÉ

Date de l'autorisation:

2004-04-27

Notice patient

                                Bimeda Version December 08 2017
_MAIN PANEL- ENGLISH: _
DIN 00142220
APPLE FLAVOUR
À LA SAVEUR DE POMME
_P R_
_SULFALEAN_
®_ _
_POWDER _
VETERINARY USE ONLY/USAGE VÉTÉRINAIRE SEULEMENT
ANTIBIOTIC/ANTIBIOTIQUE
NET 20 LBS (9.1 KG)
ACTIVE INGREDIENTS:
Each 590 g contains
Sodium
Sulfathiazole…………………………………………………….
189 g
Sodium
Sulfamethazine…………………………………………………
378 g
INDICATIONS:
CATTLE AND SHEEP: As an aid in the treatment of bacterial infections,
such as foot abscess, bacillary enteritis,
metritis, mastitis, septicemia accompanying acute mastitis and
shipping fever complex, and bacterial respiratory
infections, caused by bacteria susceptible to sulfathiazole and/or
sulfamethazine.
CALVES: As an aid in the treatment of the following conditions caused
by bacteria susceptible to sulfathiazole
and/or sulfamethazine: secondary infections in enteritis and bacterial
respiratory disease.
SWINE: As an aid in the treatment of the following conditions caused
by bacteria susceptible to sulfathiazole and/or
sulfamethazine: bacterial enteritis, acute mastitis, metritis, and
bacterial respiratory diseases.
HORSES: As an aid in the treatment of the following conditions caused
by bacteria susceptible to sulfathiazole
and/or sulfamethazine: strangles, acute bacterial infections,
bacterial enteritis, and many secondary bacterial
infections associated with respiratory virus infections.
DOSAGE AND ADMINISTRATION:
_To reduce the development of antimicrobial resistance and maintain
effectiveness, use this antibiotic prudently and _
_for the shortest duration required to achieve the desired clinical
outcome._
PREPARATION OF 12.5% SOLUTION: Dissolve 590 g (900 mL) in water to
make a total volume of 4.54 litres of solution
(graduated scoop enclosed).
DOSAGE: Administer as a drench, 1st day: 40 mL of 12.5% solution to
each 25 kg of body weight. 2nd day and
following days: one half of the above dosage.
WATER TROUGH MEDICATION: Dissolve 590 g in enough water to med
                                
                                Lire le document complet
                                
                            

Documents dans d'autres langues

Notice patient Notice patient anglais 16-01-2018

Afficher l'historique des documents